Hierarchical scaffolding of an ERK1/2 activation pathway

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Vetterkind, Susanne ^a   Poythress, Ransom H ^a   Lin, Qian Qian ^a   Morgan, Kathleen G ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Actin; Extracellular signal regulated kinase; Mitogen activated kinase; Phorbol ester; Scaffold protein

Indexed keywords

CAVEOLIN 1; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; RAF PROTEIN; SMALL INTERFERING RNA; B RAF KINASE; BRAF PROTEIN, RAT; CAV PROTEIN, RAT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; KSR 1 PROTEIN KINASE; KSR-1 PROTEIN KINASE; PROTEIN KINASE; CAV1 PROTEIN, RAT;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; ANIMAL; CELL LINE; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLIN 1; CELL LINE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RAS GTPASE-ACTIVATING PROTEINS; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84883292777     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-65     Document Type: Article

References (58)

1. Modularity and functional plasticity of scaffold proteins as p(l)acemakers in cell signaling. Pan CQ, Sudol M, Sheetz M, Low BC, Cell Signal 2012 24 2143 2165 10.1016/j.cellsig.2012.06.002 22743133
2. Protein-Protein Interactions in the yeast pheromone response pathway stesp interacts with all members of the map kinase cascade. Printen JA, Sprague GF, Genetics 1994 138 609 619 7851759
3. KSR modulates signal propagation within the MAPK cascade. Therrien M, Michaud NR, Rubin GM, Morrison DK, Genes Dev 1996 10 2684 2695 10.1101/gad.10.21.2684 8946910
4. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Kolch W, Nat Rev Mol Cell Biol 2005 6 827 37 10.1038/nrm1743 16227978
5. The ERK cascade: distinct functions within various subcellular organelles. Wortzel I, Seger R, Genes Cancer 2011 2 195 209 10.1177/ 1947601911407328 21779493
6. Phosphorylation-dependent paxillin-erk association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Ishibe S, Joly D, Zhu X, Cantley LG, Haven N, Mol Cell 2003 12 1275 1285 10.1016/S1097-2765(03)00406-4 14636584
7. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y, J Biol Chem 1997 272 33416 33421 10.1074/jbc.272.52.33416 9407137
8. Co-purification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP, J Biol Chem 1996 271 9690 9697 10.1074/jbc.271.16.9690 8621645
9. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. Mineo C, James GL, Smart EJ, Anderson RG, J Biol Chem 1996 271 11930 11935 10.1074/jbc.271.20.11930 8662667
10. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP, FEBS Lett 1998 428 205 211 10.1016/S0014-5793(98)00470-0 9654135
11. Stimulus-specific activation and actin dependency of distinct, spatially separated ERK1/2 fractions in A7r5 smooth muscle cells. Vetterkind S, Saphirstein RJ, Morgan KG, PLoS one 2012 7 30409 10.1371/journal.pone.0030409 22363435
12. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Je H-D, Gallant C, Leavis PC, Morgan KG, Am J Physiol-Heart Circ Physiol 2004 286 91 8 12969891
13. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP, EMBO J 1998 17 6633 48 10.1093/emboj/17.22.6633 9822607
14. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Leinweber BD, Leavis PC, Grabarek Z, Wang CL, Morgan KG, Biochem J 1999 344 Pt 1 117 123 10548541
15. Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells. Burgstaller G, Gimona M, Am J Physiol-Heart Circ Physiol 2005 288 3001 H3005 10.1152/ajpheart.01002.2004 15695563
16. Signaling dynamics of the KSR1 scaffold complex. McKay MM, Ritt D, Morrison DK, Proc Natl Acad Sci USA 2009 106 11022 7 10.1073/pnas.0901590106 19541618
17. A dual role for IQGAP1 in regulating exocytosis. Rittmeyer EN, Daniel S, Hsu S-C, Osman M, J Cell Sci 2008 121 Pt 3 391 403 18216334
18. Elucidation of the interaction of calmodulin with the IQ motifs of IQGAP1. Li Z, Sacks DB, J Biol Chem 2003 278 4347 52 10.1074/jbc.M208579200 12446675
19. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Roy M, Li Z, Sacks DB, Mol Cell Biol 2005 25 7940 7952 10.1128/MCB.25.18.7940-7952. 2005 16135787
20. IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling. Ren J-G, Li Z, Sacks DB, J Biol Chem 2008 283 22972 82 10.1074/jbc.M804626200 18567582
21. ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. Sbroggiò M, Bertero A, Velasco S, Fusella F, De Blasio E, Bahou WF, Silengo L, Turco E, Brancaccio M, Tarone G, J Cell Sci 2011 124 Pt 20 3515 3524 22010199
22. Melusin Is a New Muscle-specific Interactor for beta 1 Integrin Cytoplasmic Domain. Brancaccio M, J Biol Chem 1999 274 29282 29288 10.1074/jbc.274.41.29282 10506186
23. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. Llobet D, Eritja N, Domingo M, Bergada L, Mirantes C, Santacana M, Pallares J, Macià A, Yeramian A, Encinas M, Moreno-Bueno G, Palacios J, Lewis RE, Matias-Guiu X, Dolcet X, Am J Pathol 2011 178 1529 15243 10.1016/j.ajpath.2010. 12.041 21435442
24. Kinase suppressor of Ras 1 is required for full ERK activation in thymocytes but not for thymocyte selection. Filbert EL, Nguyen A, Markiewicz MA, Fowlkes BJ, Huang YH, Shaw AS, Eur J Immunol 2010 40 3226 3234 10.1002/eji.201040349 20865788
25. Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation. Shalin SC, Hernandez CM, Dougherty MK, Morrison DK, Sweatt JD, Neuron 2006 50 765 779 10.1016/j.neuron.2006.04.029 16731514
26. Signal transduction: hanging on a scaffold. Burack WR, Shaw a S, Curr Opin Cell Biol 2000 12 211 216 10.1016/S0955-0674(99)00078-2 10712921
27. Kinase Suppressor of Ras Inhibits the Activation of Extracellular Ligand-regulated (ERK) Mitogen-activated Protein (MAP) Kinase by Growth Factors, Activated Ras, and Ras Effectors. Joneson T, J Biol Chem 1998 273 7743 7748 10.1074/jbc.273.13.7743 9516483
28. Pravastatin normalizes ET-1-induced contraction in the aorta of type 2 diabetic OLETF rats by suppressing the KSR1/ERK complex. Nemoto S, Taguchi K, Matsumoto T, Kamata K, Kobayashi T, Am J Physiol-Heart Circ Physiol 2012 303 893 902 10.1152/ajpheart.01128.2011 22886408
29. IQGAP1, a Rac- and Cdc42-binding protein, directly binds and cross-links microfilaments. Bashour a M, Fullerton a T, Hart MJ, Bloom GS, J Cell Biol 1997 137 1555 1566 10.1083/jcb.137.7.1555 9199170
30. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius K, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson L-G, Landegren U, Nat Methods 2006 3 995 1000 10.1038/nmeth947 17072308
31. Scaffolding proteins and non-proliferative functions of ERK1/2. Appel S, Morgan KG, Commun Integr Biol 2010 3 354 356 10.4161/cib.3.4.11832 20798825
32. ERK dimers and scaffold proteins: unexpected partners for a forgotton (cytoplasmic) task. Casar B, Crespo P, Cell Cycle 2009 8 1007 1013 10.4161/cc.8.7.8078 19279408
33. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac L, Carter JE, Ottlinger ME, Karnovsky MJ, J Cell Physiol 1997 172 69 78 10.1002/(SICI)1097-4652(199707)172: 1<69::AID-JCP8>3.0.CO;2-B 9207927
34. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM, Mol Cell Biol 1996 16 5839 5845 8816498
35. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway. Wang X, Wang Q, Hu W, Evers BM, Oncogene 2004 23 1885 1895 10.1038/sj.onc.1207312 14981539
36. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. King AJ, Sun H, Diaz B, Barnard D, Miao W, Bagrodia SMM, Nature 1998 396 180 183 10.1038/24184 9823899
37. IQGAP1 modulates activation of B-Raf. Ren J-G, Li Z, Sacks DB, Proc Natl Acad Sci U S A 2007 104 10465 10469 10.1073/pnas.0611308104 17563371
38. Isolated endosomes from quiescent rat liver contain the signal transduction machinery: differential distribution of activated Raf-1 and Mek in the endocytic compartment. Pol a, Calvo M, Enrich C, FEBS Lett 1998 441 34 38 10.1016/S0014-5793(98)01517-8 9877160
39. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. Sbroggiò M, Carnevale D, Bertero A, Cifelli G, De Blasio E, Mascio G, Hirsch E, Bahou WF, Turco E, Silengo L, Brancaccio M, Lembo G, Tarone G, Cardiovasc Res 2011 91 456 464 10.1093/cvr/cvr103 21493702
40. Partner exchange: protein-protein interactions in the Raf pathway. Wimmer R, Baccarini M, Trends Biochem Sci 2010 35 660 668 10.1016/j.tibs.2010.06.001 20621483
41. Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae. Wickström S, Lange A, Hess MW, Polleux J, Spatz JP, Krüger M, Pfaller K, Lambacher A, Bloch W, Mann M, Huber L, Fässler R, Dev Cell 2010 19 574 588 10.1016/j.devcel.2010.09.007 20951348
42. Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. Freeman AK, Ritt D, Morrison DK, Mol Cell 2013 49 751 758 10.1016/j.molcel.2012.12.018 23352452
43. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Garnett MJ, Rana S, Paterson H, Barford D, Marais R, Mol Cell 2005 20 963 969 10.1016/j.molcel.2005.10.022 16364920
44. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Ritt D, Monson DM, Specht SI, Morrison DK, Mol Cell Biol 2010 30 806 819 10.1128/MCB.00569-09 19933846
45. Active Ras induces heterodimerization of cRaf and BRaf. Weber CK, Slupsky JR, Kalmes H, Rapp UR, Cancer Res 2001 61 3595 3598 11325826
46. Regulation and Role of Raf-1 / B-Raf Heterodimerization. Rushworth LK, Hindley AD, Neill EO, Kolch W, Mol Cell Biol 2006 26 2262 2272 10.1128/MCB.26.6.2262-2272.2006 16508002
47. Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf. Brummer T, Naegele H, Reth M, Misawa Y, Oncogene 2003 22 8823 8834 10.1038/sj.onc.1207185 14654779
48. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Roberts PJ, Der CJ, Oncogene 2007 26 3291 310 10.1038/sj.onc.1210422 17496923
49. RAS oncogenes: the first 30 years. Malumbres M, Barbacid M, Nat Rev Cancer 2003 3 459 465 10.1038/nrc1097 12778136
50. Mutations of the BRAF gene in human cancer. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson B, Cooper C, Shipley J, et al. Nat Geosci 2002 417 949 954
51. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Camici GG, Steffel J, Akhmedov A, Schafer N, Baldinger J, Schulz U, Shojaati K, Matter CM, Yang Z, Lüscher TF, Tanner FC, Circulation 2006 114 1512 1521 10.1161/CIRCULATIONAHA.106.638460 17000906
52. BMI-1026 treatment can induce SAHF formation by activation of Erk1/2. Seo H-J, Park HJ, Choi HS, Hwang S-Y, Park J-S, Seong Y-S, BMB Rep 2008 41 523 528 10.5483/BMBRep.2008.41.7.523 18682036
53. Tumor necrosis factor-alpha enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway. Yu H-N, Lee Y-R, Noh E-M, Lee K-S, Song E-K, Han M-K, Lee Y-C, Yim C-Y, Park J, Kim B-S, Lee S-H, Lee SJ, Kim J-S, Int J Hematol 2008 87 189 194 10.1007/s12185-008-0037-z 18256785
54. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Kimes BW, Brandt BL, Exp Cell Res 1976 98 349 366 10.1016/0014-4827(76)90446-8 943301
55. A comparative molecular analysis of four rat smooth muscle cell lines. Firulli AB, Han D, Kelly-Roloff L, Koteliansky VE, Schwartz SM, Olson EN, Miano JM, In Vitro Cell Dev Biol Anim 1998 34 217 226 10.1007/s11626-998-0127-5 9557939
56. Binding of Par-4 to the actin cytoskeleton is essential for Par-4/Dlk-mediated apoptosis. Vetterkind S, Illenberger S, Kubicek J, Boosen M, Appel S, Naim HY, Scheidtmann K-H, Preuss U, Exp Cell Res 2005 305 177 191
57. Par-4: a new activator of myosin phosphatase. Vetterkind S, Lee E, Sundberg E, Poythress RH, Tao TC, Preuss U, Morgan KG, Mol Biol Cell 2010 21 1214 1224 10.1091/mbc.E09-08-0711 20130087
58. Actin polymerization in differentiated vascular smooth muscle cells requires vasodilator-stimulated phosphoprotein. Kim HR, Graceffa P, Ferron F, Gallant C, Boczkowska M, Dominguez R, Morgan KG, Am J Physiol-Cell Physiol 2010 1 559 571